Skip to main content
Company raises $45M for AI-based medication research

Deep learning company Atomwise has raised $45 million in a Series A round to further its work to discover new drugs. The company uses artificial intelligence to analyze millions of compounds for their potential as medications and discover their effect on the human body.

Full Story: